BIGHAT
Live / Applied — Third extension granted (statement of use) (as of 16 Dec 2025)
What this means for you
Not registered yet, but its 26 Jun 2023 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98058836
- Mark type
- Stylized text
- Filed
- 26 Jun 2023
- Published for opposition
- 23 Apr 2024
- Attorney of record
- Laura Miller
Goods and services
- Class 001 — Chemicals: Biochemicals, namely, antibodies and protein molecules for use in in vitro scientific or research use
- Class 005 — Pharmaceuticals: Pharmaceuticals for use in the treatment of oncological, autoimmune, infectious, endocrinal, and ocular diseases and disorders; antibodies and protein molecules for use in medical diagnosis and treatment of diseases and disorders
Owner
- Bighat Biosciences, Inc., San Mateo, CA, US
- Bighat Biosciences, Inc., San Mateo, CA, US
Prior registrations
Prosecution history
- 17 Dec 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 16 Dec 2025 — SOU EXTENSION 3 GRANTED
- 16 Dec 2025 — SOU EXTENSION 3 FILED
- 16 Dec 2025 — SOU TEAS EXTENSION RECEIVED
- 18 Jun 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 17 Jun 2025 — SOU EXTENSION 2 GRANTED
- 17 Jun 2025 — SOU EXTENSION 2 FILED
- 17 Jun 2025 — SOU TEAS EXTENSION RECEIVED
- 03 Mar 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 17 Dec 2024 — SOU EXTENSION 1 GRANTED
- 17 Dec 2024 — SOU EXTENSION 1 FILED
- 17 Dec 2024 — SOU TEAS EXTENSION RECEIVED
- 18 Jun 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 02 May 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 25 Apr 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED